|
116 |
The Importance Of Primary And Secondary Drying And Their Impact On Lyophilization
|
관리자 |
2025-04-30 |
87 |
|
115 |
Why Pharma Risk Assessments Should Include 'Working Together Alone'
|
관리자 |
2025-04-30 |
83 |
|
114 |
When to Replace your HEPA Filter – According to a Cleanroom Expert
|
관리자 |
2025-04-30 |
84 |
|
113 |
Why You Need A Raw Material Control Strategy
|
관리자 |
2025-04-30 |
81 |
|
112 |
Sterilisation Processes – Requirements and Definitions
|
관리자 |
2025-04-01 |
262 |
|
111 |
How to Implement Quality Oversight at Shop Floor Level
|
관리자 |
2025-04-01 |
263 |
|
110 |
Quality Risk Management: What’s new in ICH Q9(R1)?
|
관리자 |
2025-04-01 |
264 |
|
109 |
FDA issues Warning Letter due to GMP Violations at Chinese Drug Manufacturer
|
관리자 |
2025-04-01 |
232 |
|
108 |
A Risk-based Approach To Filter Integrity Testing Annex 1 Requirements For Biologics DS
|
관리자 |
2025-02-28 |
312 |
|
107 |
Pharmaceutical stability testing: An overview of stability
|
관리자 |
2025-02-28 |
292 |
